Led · Series A · Nov 2024

Prism Worldwide develops patented, American-made technology that converts end-of-life tires into high-performance thermoplastic elastomers (TPEs) and polymer intermediates for elastomer and plastic markets. Its process reverses the polymerization of tire rubber in an energy-efficient, low capital-intensive way to produce functional, flexible materials that can be reincorporated into rubber- and plastic-based products. The company says its materials allow higher concentrations of recycled content without sacrificing product quality and can be recycled again at end of life. Prism reports it has reached commercial viability, evidenced by an initial round of sales and sales commitments for its TPEs, and is producing a product available for purchase today. Prism plans to use new capital to accelerate commercialization by consolidating operations, making capital investments in technology and equipment, and expanding its team. The company emphasizes circularity and reduced carbon emissions as key value propositions for customers and petrochemical partners seeking more sustainable feedstocks. PRISM Worldwide has developed a patented process that converts 100% of end-of-life tires into PRISM Thermoplastic Rubber (PTR), a like-new rubber and plastic polymer. PTR is used to replace virgin material in tires, roofing, paving asphalts, and industrial rubber products. The company says its process emits less than 15% of the greenhouse gases produced in the manufacture of synthetic rubber. With expanded R&D capability, PRISM aims to create additional applications for its technology, including materials for plastics manufacturing. The company is based in Kirkland, Washington, with its plant and laboratory located in Reno, Nevada. PRISM reported that the latest financing will support expanded operations and research and development.

Led · Series A · May 2022

KLOwen Braces builds the Stride Custom Braces system, a 7–7 fully individualized braces solution that leverages 3D printing, artificial intelligence and digital indirect bonding. The product to date has featured metal brackets and the company plans to premiere a new 3D‑printed clear brackets solution at the American Association of Orthodontists Annual Session in Miami Beach, May 21–24, 2022. KLOwen says Stride reduces months of treatment, the number of office visits, chair time and patient discomfort versus traditional braces. The company reports that orthodontists using Stride typically double both their capacity and net profit per hour without adding staff or clinic hours. The article notes fixed‑appliance patients still represent nearly 70% of all orthodontics cases. KLOwen was founded in 2019 by Dr. Brandon Owen and is based in Austin, Texas; its Stride Custom Braces are patented. KLOwen Braces, founded by Dr. Brandon Owen in 2019 and based in Fort Collins, Colo., develops the KLOwen Custom Braces System, the world’s first in-office, same-day custom braces solution using prefabricated, modular brackets. The system leverages advanced software, 3D printing, a kit of 27 custom-shaped brackets and 3D-printed indirect bonding (IDB) trays to place and bond brackets precisely as approved in the software. It is designed to work on any orthodontic case, including those requiring functional appliances, expansion or surgery, with the goal of increasing doctor efficiency and reducing patient discomfort and treatment time. The company holds seven patents with 20 more patents pending. KLOwen positions its offering to enhance efficiency and profitability for orthodontists at a price point stated to be well below other custom solutions. The company recently received a $50,000 investment from the American Association of Orthodontists, and AAO leadership will take a board seat to help advance adoption and product development.

Led · Series B · Apr 2022

Iris Telehealth provides telepsychiatry services to health systems and community health centers across the U.S., supplying clinicians, staff support, and operational know-how to build sustainable telepsychiatry departments. The company identifies best-fit providers for each partner and emphasizes long-term commitment to meeting partner needs. Founded in 2013 and led by CEO Andy Flanagan, Iris now serves almost 200 hospitals and community health centers. The business plans to use recent funding to grow its clinical operations team and augment both clinical and corporate staff. It also intends to scale its go-to-market strategy and expand product and technology capabilities. Iris raised a $40M Series B to fund these growth and product initiatives.

Led · Series B · Aug 2021

HAGAR develops GWave, a non-invasive continuous glucose monitor that uses radio-frequency (RF) waves to measure blood glucose in real time rather than interstitial fluid. The device integrates with Bluetooth and smartphones and includes an automated alert system for significant glucose fluctuations. In a proprietary study at the Weizmann Institute of Science (n=75) GWave achieved a mean MARD of 6.7%, with 97% of points in Zone A and 3% in Zone B on the Clarke Error Grid. The study included 34 people with diabetes (82% Type 1), ten pregnant people with diabetes, and 31 without diabetes; monitoring was performed on the wrist and compared to BGM and two commercial CGMs. A hypoglycemic test with Dr. Irl Hirsch demonstrated the device tracked a drop from 180 to 46 mg/dL accurately. HAGAR holds an FDA Breakthrough Device Designation (2021) and plans additional U.S. and Israeli studies in late 2023, aiming for eventual smartwatch integration at low cost to broaden access. HAGAR's core product, GWave, is described as the world’s first non-invasive continuous glucose monitor that uses radio-frequency (RF) waves to measure blood glucose rather than interstitial fluid. The company says GWave yields over 90% detection rates and clinical testing cited greater than 95% accuracy in at least one trial. GWave First Generation is about a third of the size of a smartphone, uses less RF than a smartphone, and connects to a smartphone app for readings. The company is developing GWave 2.0 as a sensor that can be integrated into a smartwatch and linked to the existing app to share data with healthcare providers. HAGAR positions the device both for diabetes management and preventive care to detect elevated glucose before diagnosis. Financially, the company has raised capital to support development and regulatory work, including a recent Series B that increases its total funding.

Led · Debt Financing · Mar 2021

Banzai is an enterprise SaaS Engagement Marketing platform that supports virtual events. Its platform includes Demio, a webinar solution for marketers, and Reach, an audience-acquisition solution that drives new ICP contacts to events. Together these products aim to accelerate marketers’ ROI through audience acquisition, attendee engagement, integrations with existing tech stacks, and metric-driven analytics. Banzai serves thousands of customers, including HubSpot, Square, Microsoft, Thermo Fisher Scientific, ActiveCampaign, TalkDesk, Argyle, and Nutshell. The company says proceeds from the announced investment will enable it to expand further to service its growing roster of customers. The press release was issued from Seattle. Banzai offers a marketing automation platform focused on experiential marketing through webinars and events, designed to help marketers grow audiences and create more engaging experiences. The company serves enterprise customers including Nextiva, Red Hat, DataRobot, and Egnyte, and more than 3,000 additional customers. In the past six months Banzai expanded its virtual event and webinar capabilities through acquisitions of High Attendance and Demio. Management says the company will use new funding to expand service for its growing roster of customers. Banzai states a near-term plan to reach profitability while maintaining a triple-digit growth rate. The company frames its mission around supporting educational experiences that enable professionals to learn, grow, and connect. Banzai offers an end-to-end Event Marketing Automation cloud SaaS platform that streamlines registration, audience targeting, invitations, and attendance for enterprise marketers. Its solution is used by more than 200 companies, including Dell, Google, Microsoft, and Oracle. Customers using Banzai have generated over 30,000 event and conference registrations worldwide. In 2019 the company doubled its topline revenue, supported 1,400 unique customer events, and grew its team by 200 percent. Banzai says it will use new funding to double headcount and expand its product and service offerings in the Event Marketing Automation category. The company positions itself to help marketers prove ROI and simplify the logistical challenges of field and regional events.